Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-05-06

Clinical Trial Update: TC02 Obese Women Using It Morphine vs PCA IV Hydromorphone for Post-Cesarean Analgesia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing morphine vs PCA IV hydromorphone for post-cesarean analgesia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • PCA IV hydromorphone (hydromorphone)

Snippet

Sponsor: Northwestern University | Conditions: Pain, Postoperative, Obesity | Phase 4 | Status: WITHDRAWN